Stock Details
BDX is Becton, Dickinson and Company's stock. Stock exchange NYSE (Currency USD). Average price in 50 days is 257.94$. Average daily volumn in 3 months 1.26M. Market cap 71.92B

Stock symbol : BDX. Exchange : NYSE. Currency : USD
Lastest price : 252.30$. Total volume : 910.92k. Market state POSTPOST
Click reload if you want to check the lastest price on market!!!

Becton, Dickinson and Company (BDX)
Last Price

Previous Close251.14
Day Range247.82-253.40
Bid247.67 x 900
Ask257.08 x 1.8k
Average Volume1.26M
Market Cap71.92B
52 Week Range229.40-277.29
Trailing P/E39.83
Foward P/E20.56
Dividend (Yield %)1.39%
Ex-Dividend Date2022-06-08

Financial Details

According to Becton, Dickinson and Company's financial reports the company's revenue in 2021 were 20.25B an increase( +17.65%) over the years 2020 revenue that were of 17.12B. In 2021 the company's total earnings were 2.09B while total earnings in 2020 were 874M( +128.83%).

Loading ...


Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors and ... extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; syringes, pen needles, and other products for diabetes; and prefillable drug delivery systems. Its BD Life Sciences segment provides specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The company's BD Interventional segment offers hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention, surgical and laparoscopic instrumentation products; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is based in Franklin Lakes, New Jersey.

Market Cap:
Total Assets:
Total Cash:

News about "Becton, Dickinson and Company"


SVB Leerink Comments on Becton, Dickinson and Companyโ€™s FY2022 Earnings (NYSE:BDX)

Source from : Defense World - 12 days ago

SVB Leerink lowered their FY2022 EPS estimates for shares of Becton, Dickinson and in a research note issued on Thursday, May 5th. SVB Leerink analyst D. Antalffy now forecasts that the medical ...See details»


Becton, Dickinson and Company (NYSE:BDX) Given Consensus Recommendation of โ€œHoldโ€ by Analysts

Source from : Defense World - 12 days ago

Becton, Dickinson and Company (NYSE:BDX โ€“ Get Rating) has received a consensus rating of โ€œHoldโ€ from the ten analysts that are currently covering the firm, Marketbeat reports. Six research analysts ...See details»

stocknewscom-upgrades-becton-dickinson-and-nysebdx-to-buy-image Upgrades Becton, Dickinson and (NYSE:BDX) to Buy

Source from : ETF Daily News - 7 days ago

Becton, Dickinson and (NYSE:BDX โ€“ Get Rating) was upgraded by from a โ€œholdโ€ rating to a โ€œbuyโ€ rating in a report issued on Saturday. Several other brokerages have also issued reports on ...See details»


Becton, Dickinson and (NYSE:BDX) Updates FY 2022 Earnings Guidance

Source from : ETF Daily News - 4 days ago

Becton, Dickinson and (NYSE:BDX โ€“ Get Rating) updated its FY 2022 earnings guidance on Monday. The company provided earnings per share (EPS) guidance of $11.15-$11.30 for the period, compared to the ...See details»

Becton, Dickinson and Company (BDX) CEO Tom Polen on Q2 2022 Results - Earnings Call Transcript

Source from : Seeking Alpha - 15 days ago

Q2 2022 Earnings Conference Call May 05, 2022, 08:00 AM ET Company Participants Francesca DeMartino - SVP, IR Tom Polen - President, CEO ...See details»

Becton, Dickinson and Co - Stock Quote 0R19

Source from : Morningstar%2c Inc. - 25 days ago

There is no one analyst in which a Quantitative Star Rating and Fair Value Estimate is attributed to; however, Mr. Lee Davidson, Head of Quantitative Research for Morningstar, Inc., is responsible ...See details»

Becton, Dickinson and Company Q2 Profit Increases, beats estimates

Source from : Business Insider - 15 days ago

(RTTNews) - Becton, Dickinson and Company (BDX) revealed earnings for its second quarter that increased from last year and beat the Street estimates. The company's bottom line totaled $431 million ...See details»

Becton, Dickinson and Company: Despite Lower COVID-19 Testing and Tough Comparables, Becton, Dickinson Continues to Grow

Source from : Yahoo Finance - 16 days ago

Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures diagnostic ...See details»

Becton, Dickinson And Co. Lifts FY22 Outlook - Update

Source from : Business Insider - 15 days ago

While announcing higher second-quarter results on Thursday, medical technology company Becton, Dickinson and Co. (BDX) raised the ...See details»

Client Profile: Becton, Dickinson & Co

Source from : - 29 days ago

A special interest's lobbying activity may go up or down over time, depending on how much attention the federal government is giving their issues. Particularly active clients often retain multiple ...See details»

Blood Collection Tubes Market to Observe Exponential Growth By 2022 to 2028 | Becton, Dickinson and Company, QIAGEN

Source from : Digital Journal - 1 days ago

Becton, Dickinson and Company, Greiner Bio-One International GmbH, QIAGEN, McKesson Medical-Surgical Inc., FL MEDICAL s.r.l., Haemonetics Corporation, AdvaCare Pharmaceuticals, Sarstedt AG & Co., ...See details»

Becton Dickinson ordered to pay $255k in hernia mesh trial

Source from : Reuters - 1 month ago

Plaintiff alleged infection, abscess caused by defective mesh implant Company still faces more than 26,000 hernia mesh claims in federal and state court The company and law firm names shown above ...See details»

Becton Dickinson: Fiscal Q2 Earnings Snapshot

Source from : Greenwich Time - 15 days ago

FRANKLIN LAKES, N.J. (AP) _ Becton Dickinson and Co. (BDX) on Thursday reported fiscal second-quarter profit of $454 million. The Franklin Lakes, New Jersey-based company said it had profit of $1 ...See details»

Becton Dickinson and Co

Source from : MSN - 16 days ago

Chairman of the Board, President, Chief Executive Officer, Chief Operating Officer Christopher DelOrefice Chief Financial Officer, Executive Vice President David Hickey +401.10 ...See details»